Henrik Ancher-Jensen
Corporate Officer/Principal chez AGILENT TECHNOLOGIES, INC.
Fortune : 11 M $ au 30/04/2024
Profil
Henrik Ancher-Jensen is currently working as the SVP & President-Order Fulfillment & Supply Chain at Agilent Technologies, Inc. He previously worked as the Vice President-Global Operations at Dako Denmark ApS from 2010 to 2012.
Mr. Ancher-Jensen completed his undergraduate degree at the University of Aarhus.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 03/05/2024 | 82 560 ( 0,03% ) | 11 M $ | 30/04/2024 |
Postes actifs de Henrik Ancher-Jensen
| Sociétés | Poste | Début |
|---|---|---|
| AGILENT TECHNOLOGIES, INC. | Corporate Officer/Principal | 01/09/2012 |
Anciens postes connus de Henrik Ancher-Jensen
| Sociétés | Poste | Fin |
|---|---|---|
Dako Denmark ApS
 Dako Denmark ApS Medical SpecialtiesHealth Technology Dako Denmark A/S designs and manufactures cancer diagnostic systems. It produces reagents, antibodies, instruments, and software solutions to make diagnoses and determine treatments for patients suffering from cancer. The firm's product areas encompass Immunohistochemistry, pharmacoDiagnostics, molecular pathology, Hematoxylin and Eosin stain, special stains, flow Cytometry, and specific proteins. The company was founded by Niels Harboe in 1966 and is headquartered in Glostrup, Denmark. | Directeur des opérations | 01/09/2012 |
Formation de Henrik Ancher-Jensen
| University of Aarhus | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AGILENT TECHNOLOGIES, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Dako Denmark ApS
Dako Denmark ApS Medical SpecialtiesHealth Technology Dako Denmark A/S designs and manufactures cancer diagnostic systems. It produces reagents, antibodies, instruments, and software solutions to make diagnoses and determine treatments for patients suffering from cancer. The firm's product areas encompass Immunohistochemistry, pharmacoDiagnostics, molecular pathology, Hematoxylin and Eosin stain, special stains, flow Cytometry, and specific proteins. The company was founded by Niels Harboe in 1966 and is headquartered in Glostrup, Denmark. | Health Technology |
